Literature DB >> 9524771

Biological aspects of macrophage-stimulating protein (MSP) and its receptor.

E J Leonard1.   

Abstract

Macrophage-stimulating protein (MSP; also known as HGF-like protein [HGFl]) is a 78 kDa plasma protein that is secreted by the liver into the circulation as single-chain, biologically inactive pro-MSP. The presence of conserved triple disulfide loops (kringles) places pro-MSP in a family of coagulation system serine protease zymogens that are activated by proteolytic cleavage. Although pro-MSP has lost enzymic activity, it has retained the activation mechanism, in that proteolytic cleavage at a single site yields biologically active disulfide-linked alpha beta-chain heterodimeric MSP. The MSP receptor is a transmembrane protein tyrosine kinase. MSP causes phosphorylation of the receptor cytoplasmic domain, association of phosphatidylinositol (PI)-3 kinase with the receptor, and phosphorylation of receptor-bound PI-3 kinase. Inhibition of PI-3 kinase by wortmannin prevents MSP action on cells. MSP stimulates motility of murine resident peritoneal macrophages. However, it does not act on exudate macrophages or blood monocytes, since these earlier maturational stages of the lineage do not express the receptor. MSP also stimulates keratinocyte cell lines, causing either chemotactic responses or increased cell numbers in culture. We suggest that pro-MSP diffuses into local tissue sites, where proteolytic cleavage to MSP results in stimulation of keratinocytes and macrophages. It possibly plays a role in tissue injury or wound healing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9524771

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  9 in total

Review 1.  The role of type II transmembrane serine protease-mediated signaling in cancer.

Authors:  Lauren M Tanabe; Karin List
Journal:  FEBS J       Date:  2016-12-24       Impact factor: 5.542

2.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway.

Authors:  Ami S Bhatt; Alana Welm; Christopher J Farady; Maximiliano Vásquez; Keith Wilson; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

3.  The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation.

Authors:  Alex B Lentsch; Peterson Pathrose; Sarah Kader; Satoshi Kuboki; Margaret H Collins; Susan E Waltz
Journal:  Shock       Date:  2007-03       Impact factor: 3.454

4.  The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Authors:  Alana L Welm; Julie B Sneddon; Carmen Taylor; Dimitry S A Nuyten; Marc J van de Vijver; Bruce H Hasegawa; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

5.  Identification and developmental expression of a macrophage stimulating 1/ hepatocyte growth factor-like 1 orthologue in the zebrafish.

Authors:  David I Bassett
Journal:  Dev Genes Evol       Date:  2003-05-23       Impact factor: 0.900

Review 6.  Novel actions of tissue-type plasminogen activator in chronic kidney disease.

Authors:  Kebin Hu; Wendy M Mars; Youhua Liu
Journal:  Front Biosci       Date:  2008-05-01

7.  Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.

Authors:  James C Glasbey; Andrew J Sanders; David C Bosanquet; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Biomedicines       Date:  2015-02-04

8.  RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice.

Authors:  Alfia Khaibullina; Elena A Adjei; Nowah Afangbedji; Andrey Ivanov; Namita Kumari; Luis E F Almeida; Zenaide M N Quezado; Sergei Nekhai; Marina Jerebtsova
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

9.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.